Protective effect of saxagliptin against renal ischaemia reperfusion injury in rats

dc.contributor.authorTekin, Suat
dc.contributor.authorBeytur, Asiye
dc.contributor.authorCakir, Murat
dc.contributor.authorTaslidere, Ash
dc.contributor.authorErden, Yavuz
dc.contributor.authorTekin, Çiğdem
dc.contributor.authorSandal, Süleyman
dc.contributor.authorErden, Yavuz
dc.contributor.authorErden, Yavuz
dc.contributor.otherFen Fakültesi, Moleküler Biyoloji ve Genetik Bölümü
dc.date.accessioned2025-10-18T10:05:00Z
dc.date.created2020
dc.date.issued2022
dc.departmentFakülteler, Fen Fakültesi, Moleküler Biyoloji ve Genetik Bölümü
dc.description.abstractSaxagliptin is an effective and selective dipeptidyl peptidase-4 (DPP-4) inhibitor. This study was designed to determine possible protective effects of saxagliptin against damage caused by renal ischaemia/reperfusion (I/R) in rats. In this study, 40 rats were divided into 4 groups (n = 10 for each). Group 1 (Control), Group 2 (I/R) in both kidneys ischaemia of 45 min was performed, and then reperfusion was applied for 24 h. Saxagliptin (Group 3: 2 mg/kg and Group 4: 10 mg/kg) was administered by oral gavage to the animals in treatment groups, before the I/R. Saxagliptin decreased the markers (BUN, Cre, NGAL, KIM-1 and IL-18) of acute renal damage in blood and kidney tissue. Saxagliptin provided increase in antioxidant enzyme levels and decrease in MDA and apoptosis. Histological results showed that the administration of saxagliptin exhibited a protective effect against renal damage caused by I/R. These results indicates that saxagliptin provide protection against kidney injury caused by I/R.
dc.description.sponsorshipInonu University Scientific Research Projects Fund [TCD-2017-647]
dc.description.sponsorshipThis study was supported by Inonu University Scientific Research Projects Fund [Project #TCD-2017-647].
dc.identifier.doi10.1080/13813455.2020.1715442
dc.identifier.endpage618
dc.identifier.issn1381-3455
dc.identifier.issn1744-4160
dc.identifier.issue3
dc.identifier.orcidTekin, Suat/0000-0002-2757-1802
dc.identifier.orcidErden, Yavuz/0000-0002-2807-6096
dc.identifier.orcidCAKIR, MURAT/0000-0002-2066-829X
dc.identifier.orcidCETIN, Asli/0000-0003-3902-3210
dc.identifier.orcidTEKIN, CIGDEM/0000-0001-9038-1924;
dc.identifier.pmid31979992
dc.identifier.scopus2-s2.0-85078474005
dc.identifier.scopusqualityQ2
dc.identifier.startpage608
dc.identifier.urihttps://doi.org/10.1080/13813455.2020.1715442
dc.identifier.urihttps://hdl.handle.net/11772/20998
dc.identifier.volume128
dc.identifier.wosWOS:000509173800001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofArchives of Physiology and Biochemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectDipeptidyl Peptidase-4 Inhibitor
dc.subjectOxidative Stress
dc.subjectSaxagliptin
dc.subjectRenal Ischaemia Reperfusion
dc.subjectLipid Peroxidation
dc.titleProtective effect of saxagliptin against renal ischaemia reperfusion injury in rats
dc.typeArticle
dc.wosindexScience Citation Index Expanded (SCI-EXPANDED)
dspace.entity.typePublication
relation.isAuthorOfPublication03e83980-c1b3-4acd-94a9-b6bc0b0a5695
relation.isAuthorOfPublication.latestForDiscovery03e83980-c1b3-4acd-94a9-b6bc0b0a5695
relation.isOrgUnitOfPublicationa3f2b1b0-24ca-4df9-b356-7ed567d66d91
relation.isOrgUnitOfPublication.latestForDiscoverya3f2b1b0-24ca-4df9-b356-7ed567d66d91

Dosyalar